XML 46 R31.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Jun. 30, 2025
Summary of Reserved Shares of Common Stock for Issuance

We have reserved shares of common stock for issuance as of June 30, 2025 as follows:

    

Common

Stock

Reserves

Stock options outstanding

 

3,954,716

Restricted stock units outstanding

 

179,155

Stock available for future grants or issuance:

 

2005 Stock Incentive Plan

2,089,443

2017 Employee Stock Purchase Plan

589,695

Total reserved shares of common stock for issuance

 

6,813,009

Summary of Options Vested and Exercisable

The summary of options vested and exercisable as of June 30, 2025 comprised:

    

    

    

Weighted

Average

Weighted

Aggregate

Remaining

Number of

Average

Intrinsic

Contractual

Shares

Exercise Price

Value

Term

Options outstanding

    

3,954,716

$

8.80

$

2,783,577

5.50

Options fully vested and expected to vest

 

3,849,106

$

8.88

$

2,715,828

5.39

Options exercisable

 

3,206,653

$

9.27

$

2,410,823

4.74

Summary of Effect of Stock Based Compensation

The table below summarizes the effect of stock-based compensation (in thousands):

Fiscal Year Ended June 30,

    

2025

    

2024

Stock-based compensation expense

$

(2,449)

$

(4,529)

Income tax expense

 

(62)

 

(97)

Net income effect

$

(2,511)

$

(4,626)

Summary of Stock Option Assumptions

Fiscal Year Ended June 30,

    

2025

2024

Dividend yield

 

Expected volatility

 

53

%  

54

%  

Average risk-free interest rate

 

4.11

%  

4.39

%  

Expected life (in years)

 

4.55

4.56

2005 Stock Incentive Plan  
Summary of Stock Option Activity

    

Shares

    

    

Weighted

Available for

Options

Average

Grant

Outstanding

Exercise Price

Balance as of June 30, 2023

 

1,057,983

4,059,282

$

10.06

Options Granted

 

(120,300)

120,300

$

6.47

Options Exercised

 

(145,293)

$

2.66

Options Forfeited / Expired

 

319,795

(319,795)

$

9.92

RSUs Granted

(200,821)

$

RSUs Forfeited

15,394

$

Balance as of June 30, 2024

 

1,072,051

3,714,494

$

10.24

Shares Added

1,000,000

$

Options Granted

(654,467)

654,467

$

5.57

Options Exercised

(57,000)

$

2.78

Options Forfeited / Expired

834,762

(834,762)

$

9.48

RSUs Granted

(226,654)

$

RSUs Forfeited

63,751

$

Balance as of June 30, 2025

2,089,443

3,477,199

$

9.67

Employee Stock Option  
Summary of Effect of Stock Based Compensation

The following table summarizes stock-based compensation expense relating to stock options for the years ended June 30, 2025 and 2024, respectively (in thousands):

Fiscal Year Ended June 30,

2025

2024

Cost of revenue

$

343

$

831

Research and development

183

1,043

Sales and marketing

154

436

General and administrative

433

1,038

Total

$

1,113

$

3,348

Employee Stock Option | 2005 Management Stock Option Plan  
Summary of Stock Option Activity

    

Shares

    

    

Weighted

Available for

Options

Average

Grant

Outstanding

Exercise Price

Balance as of June 30, 2023

 

71,983

826,717

$

3.29

Options Exercised

 

(114,200)

$

4.16

Balance as of June 30, 2024

 

71,983

712,517

$

3.15

Options Exercised

(134,000)

$

3.12

Options Forfeited / Expired

101,000

(101,000)

$

6.28

Plan Shares Expired

(172,983)

Balance as of June 30, 2025

477,517

$

2.49

Employee Stock Option | 2005 Stock Incentive Plan  
Summary of Stock Options Outstanding and Exercisable under All Stock Option Plans

The following table summarizes information about stock options outstanding and exercisable under all stock option plans as of June 30, 2025:

Options Outstanding

Options Exercisable

Weighted

Range of

Average

Weighted

Weighted

Exercise

Number of

Remaining

Average

Number of

Average

Prices

    

Shares

    

Contractual Life

    

Exercise Price

    

Shares

    

Exercise Price

$1.80

12,700

1.66

$

1.80

12,700

$

1.80

$2.50

547,929

2.15

$

2.50

547,929

$

2.50

$3.40-$5.71

496,934

7.83

$

4.93

133,809

$

4.02

$5.73-$7.96

424,940

7.12

$

6.94

191,029

$

7.55

$8.20-$11.23

295,951

4.54

$

10.07

271,708

$

10.10

$11.36

1,970,656

5.80

$

11.36

1,853,377

$

11.36

$11.47-$12.45

126,656

4.75

$

11.98

117,151

$

11.99

$13.75

65,400

3.04

$

13.75

65,400

$

13.75

$14.40

3,550

1.58

$

14.40

3,550

$

14.40

$19.11

10,000

5.29

$

19.11

10,000

$

19.11

$1.80-$19.11

3,954,716

5.50

$

8.80

3,206,653

$

9.27

Restricted stock units  
Summary of Effect of Stock Based Compensation

The following table summarizes stock-based compensation expense relating to RSUs for the years ended June 30, 2025 and 2024, respectively (in thousands):

Fiscal Year Ended June 30,

2025

2024

Cost of revenue

$

411

$

287

Research and development

350

260

Sales and marketing

152

147

General and administrative

120

125

Total

$

1,033

$

819

Restricted stock units | 2005 Stock Incentive Plan  
Summary of RSU Activity

Weighted Average

Grant Date

Shares

Fair Value per Share

Non-vested RSUs as of June 30, 2024

 

185,427

$

7.55

RSUs granted

 

226,654

$

5.71

RSUs released

 

(169,175)

$

7.54

RSUs forfeited

 

(63,751)

$

6.20

Non-vested RSUs as of June 30, 2025

 

179,155

$

5.71

Employee Stock Purchase Plan  
Summary of Effect of Stock Based Compensation

The following table summarizes stock-based compensation expense relating to the ESPP for the years ended June 30, 2025

and 2024, respectively (in thousands):

Fiscal Year Ended June 30,

2025

2024

Cost of revenue

$

98

$

119

Research and development

120

120

Sales and marketing

46

62

General and administrative

39

61

Total

$

303

$

362

Summary of Employee Stock Purchase Plan (ESPP) assumptions

Fiscal Year Ended June 30,

2025

2024

Dividend yield

Expected volatility

57

%  

57

%

Average risk-free interest rate

2.48

%  

2.16

%  

Expected term (in years)

0.50

0.50